Popular Biotech News, Healthcare News and Pharma News

18:22 EDT 1st October 2014 | BioPortfolio

Elimidrol Reviews Roll In, Continue to Astonish

Success rate of Sunrise Nutraceuticals' new opiate withdrawal detox formula reveals product that works exceptionally well for users. Dallas, TX (PRWEB) March 04, 2014 Several months after its much-anticipated release, Sunrise Nutraceuticals’ one-of-a-kind opiate withdrawal support supplement continues to impress. As the Elimidrol reviews pour in, feedback has been overwhelmingly positive—...

Robin McGraw Launches When Georgia Smiled: The Robin McGraw Revelation Foundation

LOS ANGELES, Oct. 7, 2013 /PRNewswire/ -- Robin McGraw, two-time New York Times bestselling author, television personality and lifelong philanthropist, proudly announces the launch of When Georgia Smiled, a 501(c)(3) non-profit organization. The foundation's mission is to create and advance programs that help women and children, especially those affected by domestic violence, live healthy, sa...

Adult Acne: Five Steps to Clear and Beautiful Skin

On September 22, 2014, Women’s Health Magazine offered its online readers a five-step plan for treating adult acne. Dr. Simon Ourian of Epione Medical Corporation comments on the report and offers his suggestions for women suffering from adult-onset acne. Los Angeles, CA (PRWEB) September 26, 2014 On September 22, 2014, Women’s Health Magazine posted an article on its website titled “5 Esse...

MSD Announces First Presentation of Early Data on the Investigational Use of Pembrolizumab in Patients with Advanced Bladder Cancer at ESMO 2014

Pembrolizumab monotherapy achieved 24 percent overall response rate in patients with PD-L1 positive, advanced bladder (urothelial) cancer Planned Phase 3 study in advanced bladder cancer to be initiated by the end of 2014 MSD, known as Merck in the United States and Canada, today announced the first presentation of data on the invest...

BD launches a new generation of disposable auto-injectors

BD Physioject™ provides an innovative solution with proven* patient acceptance, ease of use and robust system functionality   Location (08 November 2011) – BD Medical, a segment of BD (Becton, Dickinson and Company), announced today the launch of the BD Physioject™ disposable auto-injector.  This clinically proven,* reliable and cost-effective system is sp...

GSK's lapatinib fails in Phase III gastric cancer trial

A Phase III trial of GlaxoSmithKline's lapatinib (Tykerb/Tyverb) in combination with chemotherapy in patients with HER2-positive advanced gastric cancer has failed. The product, a human epidermal growth factor receptor-2 (HER2) and epidermal.....

GE Healthcare to Showcase Latest Innovations in Anesthesia Delivery and Patient Monitoring at ANESTHESIOLOGY 2013

Groundbreaking technologies deliver patient-centered, actionable, intelligent solutions to enhance perioperative care GE Healthcare will introduce several new technologies that demonstrate its ongoing commitment to improving the quality of patient care at ANESTHESIOLOGY 2013, the annual meeting of the American Society of Anesthesiologists, takin...

23 And Me And the FDA

As everyone will have heard the personal-genomics company 23 and Me was told by the FDA to immediately stop selling their product, a direct-to-consumer DNA sequence readout. Reaction to this has been all over the map. I'll pick a couple of the viewpo...

Biomet Lawsuit News: Biomet Asks for Dismissal of Four Cases, Notes Rottenstein Law Group LLP

The firm is actively filing Biomet Magnum M2a lawsuits on behalf of those who have suffered metallosis, premature device failure, and other serious complications allegedly caused by the metal-on-metal hip device. Rockville Centre, NY (PRWEB) January 17, 2014 The Biomet companies that are defendants in multidistrict litigation over the M2a Magnum hip implant products have filed a motion with the c...

Prostate Cancer Drug Pipeline Update 2014

Recently added to the BioPortfolio report store, Prostate Cancer Drug Pipeline Update 2014 is a new report from BioSeeker published on 2014-01-13. This report is available in Desktop App plus Online Access to Updates (One Year) from $2248. Extra value: One year of free online updates included with this product Cancer of the prostate is the second most frequently diagnosed cancer in men in the US...

Opiate Withdrawal Relief Supplement, Elimidrol Begins 2014 with Breakthrough Success

Citing effectiveness and unparalleled demand, Sunrise Nutraceuticals backs #1 rated opiate withdrawal relief supplement with 100% money-back guarantee Boca Raton, Fla. (PRWEB) February 12, 2014 Since its introduction last year, Elimidrol by Sunrise Nutraceuticals has already set itself apart from the competition by creating a truly effective opiate withdrawal supplement in an industry full of ine...

Michael Strahan Takes on New Role as Spokesperson for Meta, a New Line of Wellness Products

Makers of Metamucil® tap former NFLer to spark a new approach to wellness Today, Meta—a new line of wellness products from the makers of Metamucil—announces its partnership with Michael Strahan, co-host of LIVE with Kelly and Michael, FOX NFL Sunday analyst, Good Morning America special co-host, and 2014 Pro Football Hall of Fame inductee for ...

Meditations of a Modern Day Bishop Provides Readers With Insight Into Mindfulness Meditation Training

Providing the steps to achieve Mindfulness Meditation, Meditations of a Modern Day Bishop Seeks to Provide Readers with a Step-by-Step Walk to a Deeper and More Meaningful Relationship with Their Creator and the People in their lives. This Compilation of Notes and Meditations has been Brought to Fruition by Retired School Teacher, Ann Kirschner. Cincinnati, OH (PRWEB) August 15, 2014 For more tha...

DEA Reclassification Of Hydrocodone Combination Meds Will Make It Harder To Fill Prescriptions For These Pain Killers

Patients who use drugs containing hydrocodone as a pain reliever or cough suppressant are going to have to jump through more hoops to get them starting next month.   The Drug Enforcement Administration is reclassifying so-called “hydrocodone combination products” from Schedule III to Schedule II under the Controlled Substances Act, which will more tightly re...

Latest Clinical Findings and Research on Headache Disorders to be Presented by Dr. Steven Baskin at the Biofeedback Federation of Europe's Annual Meeting in Rome, Italy

U.S. expert Dr. Steven Baskin, will share his knowledge in the field of headache disorders with an international audience at the next BFE Annual Meeting taking place March 24-28, 2015 in Rome, Italy. In addition to his presentation on scientific day, he will teach a 2-day workshop for health practitioners. London, England (PRWEB) September 30, 2014 The Biofeedback Federation of Europe is pleased ...

Astellas goes solo in its key urology market.

Datamonitor - In a bid to further increase its presence in the urology market, Astellas has announced that it will no longer co-promote Vesicare in the US with its partner GlaxoSmithKline. While Astellas is now faced with driving Vesicare's US sales alone, it is also laying the groundwork for its first-in-class follow-on drug mirabegron and reinforcing its position in the overactive bladd...

Thermo Fisher Scientific Freezing Containers Now Accommodate Larger Tube Sizes

Thermo Scientific Nalgene Mr. Frosty Freezing Containers Provide Expanded Tube Compatibility for Cost-effective Cryopreservation of Cells ROCHESTER, N.Y., (February 1, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Nalgene Mr. Frosty line of freezing containers now accommodates 3.6, 4.5 and 5.0 mL cryotubes. Desig...

Left-handed? Different bodies, different minds

We like to think of ourselves as rational creatures, absorbing information, weighing it carefully, and making thoughtful decisions. But, as it turns out, we're kidding ourselves. Over the past few decades, scientists have shown there are many different internal and external factors influencing how we think, feel, communicate, and make decisions at any given moment. One particularly powerful influe...

GE Healthcare Life Sciences launches Capto Core 700 chromatography medium for viruses and other large biomolecules

High productivity alternative to group separation for intermediate purification and polishing,  offering higher sample loads and flow rates than gel filtration April 2nd 2012: GE Healthcare’s Capto Core 700 is a multimodal chromatography medium (resin) designed for intermediate purification and polishing of viruses and other large biomolecules. Capto Core 700 offers a range of pe...

FOREST LABORATORIES AND NABRIVA THERAPEUTICS SIGN AGREEMENT.

   Vienna (Austria), June 1, 2012 - Forest Laboratories and Nabriva Therapeutics announced today they have entered into an agreement for the development of Nabriva’s novel antibacterial agent, BC-3781.  Pursuant to the agreement, Forest will provide Nabriva with $25 million, and fund and conduct in collaboration with Nabriva, certain development activities related to BC-37...

Phagenesis Launches First Treatment for Acute Dysphagia

Barcelona - 25th October 2012 - Phagenesis today launches the world's first approved treatment for acute dysphagia following stroke. The Phagenyx™ system delivers calibrated electrical stimulus to the throat (oropharynx) for 10 minutes a day for three consecutive days to patients who suffer from dysphagia – the inability to swallow safely - a debilitating condition that affe...

GE Healthcare Life Sciences launches IN Cell Analyzer 2200 for super-fast and sensitive high-content cell imaging

Flexible and efficient cell imaging system for a broad range of high-content analysis assays   December 14th 2012: GE Healthcare’s IN Cell Analyzer 2200 is a high-speed, flexible, modular imaging system suitable for both investigative microscopy and automated high-content screening of organelles, cells, tissues and whole organisms. The IN Cell Analyzer 2200 can be configured to...

Screening Test for Stuttering

A screening test for children starting school that could accurately detect early signs of a persistent stutter is a step closer, British experts say. The Wellcome Trust team says a specific speech test accurately predicts whose stutter will persist into their teens. About 1 in 20 develops a stutter before age, but just one in 100 stutter as a teen and identifying these children has so far be...

New Research Report on Antidepressants Market to 2018 by MarketResearchReports

Albany, NY, February 24, 2013 --(PR.com)-- Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives GBI Research, the leading business intelligence provider, has released its latest research, Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptak...

Immuno Biotech organises world's first GcMAF Immunology Conference

St Peter Port, Guernsey - 25 February 2013 - The world's first GcMAF conference will be held on the19th, 20th and 21st of April in the attractive woodland Conference Centre at the Holiday Inn Frankfurt, Germany. Sponsored by Immuno Biotech Ltd, the conference will have talks by leading scientists and doctors from around the world and feature new research papers on the uses of GcMAF to rest...

Cell sugar concentrations affect hyaluronan production and cancer growth

(University of Eastern Finland) According to a recent University of Eastern Finland study, elevated cell sugar concentrations increase the production of hyaluronan which, in turn, promotes cancer growth. Regulating the production of hyaluronan may be...

TAS266: Development discontinued

mAb Process Design and Scale Up to 1000L Single Use Multiproduct GMP Facilities

On the second day of the upcoming Asia Antibody Congress 2013, Mr. Bo Kara will be speaking on the topic “mAb Process Design and Scale [...]

MRI Interventions Reports 2012 Financial Results

MEMPHIS, Tenn., March 7, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCBB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the fourth quarter and full year ended December 31, 2012. The Company also announced ...

Astellas, Ambit End FLT3 Pact

Ambit regains all rights, will continue development

Insulindependence to Host North American Conference on Diabetes and Exercise in 2013

SAN DIEGO, March 14, 2013 /PRNewswire-iReach/ -- Insulindependence announced today that it will be hosting the next North American Conference on Diabetes and Exercise in San Diego, California, on August 16-18, 2013. 

 The conference was previously hosted by the Diabetes Exercise and Sports Association (DESA), prior to their merge with Insulindependence in 2012. 

 "Our s...

Docs: Overuse of ADHD drugs

Read more about Docs: Overuse of ADHD drugsComments

Entropic, Telepath Deliver First AVS+ High Definition Set-Top Box Platform for China Satellite, Cable/IP and Terrestrial Markets

BEIJING (China Content Broadcasting Network Exhibition – Hall: 3; Booth # 3403), March 21, 2013 (GLOBE NEWSWIRE) -- Entropic (Nasdaq:ENTR), a world leader in semiconductor solutions for the connected home, and Telepath Technologies Co., Ltd., a fabless integrated circuit (IC) solution provider in the multimedia broadcasting market, announced today the first Audio Video Coding Standard (AVS+) ...

Researchers evaluate prescribing practices of community matrons

An evaluation of the prescribing practices of community matrons at one NHS trust using a validated tool found they were doing so appropriately and compared favourably to published data on GP prescribing.

Russian health care regulatory agency gets new leader

Mikhail Murashko, health minister for the Komi Republic, has been tapped as the new head of Roszdravnadzor, Russia's health c -More- 

Thermo Fisher wins ISO certification for US facilities

US-based Thermo Fisher Scientific has announced that its US-based facilities have received ISO 13485 certification.

Co-promotion and Co-marketing: recent partnering industry trends

Two major forms of joint marketing are used to promote a product on the market, namely co-promotion and co-marketing. They are also referred to as joint marketing alliances. Co-marketing has been present in the pharmaceutical industry for much longer than co-promotion. Co-promotion deals are an increasingly common feature of partnering deals as smaller companies, in [...]The post Co-promotion and ...

Update: Immupharma explores retention of Lupuzor rights

The company is also still in discussions with a number of potential partners over a licensing deal for Lupuzor.

Acute inflammatory arthritis: Monoarthritis risk stratification in Lyme disease

In Lyme disease endemic areas, a noninvasive clinical prediction model to distinguish septic arthritis from Lyme arthritis would be useful, especially in children. A new study suggests that in highly selected patients, such prediction might be possib...

Washington State Approves Biologix Solutions Online HIV Training for Healthcare Professionals Seeking License to Practice

Seattle, WA, April 12, 2013 --(PR.com)-- Biologix Solutions LLC, a leader in online continuing education for nursing, dental, medical, physical therapy, occupational therapy and other healthcare professionals offers Washington State Department of Health approved online mandatory HIV/AIDS 7 Hours, 4 Hours, 3 Hours and 2 Hours training for all healthcare professionals. If you work as a health care...

Anti-TNF therapy linked to increased risk of melanoma skin cancer

Rheumatoid arthritis patients who use anti-tumour necrosis factor (anti-TNF) therapy may experience an increase in their risk of malignant melanoma, a form of skin cancer, scientists have found.Anti-TNF therapy was pioneered by Arthritis Research UK and has helped to treat large numbers of people with inflammatory forms of arthritis.However, due to its dampening effects on the immune system, there...

DMUC5754A: Phase I data

ARN-810: Phase I started

Marine ecosystems: Overfishing in west Africa by EU vessels

China is not the only culprit threatening the marine ecosystems of west Africa through overfishing (Nature496, 18, 201310.1038/496018a). The region has been the fish basket of southern Europe since the 1960s, and the European Union (EU) is going to

Albuquerque Numotion Branch Moves to New Location

ALBUQUERQUE, N.M, April 19, 2013 /PRNewswire/ -- The Numotion branch in Albuquerque, NM has moved to a new location. (Logo: http://photos.prnewswire.com/prnh/20130402/CG87448LOGO) (Photo: http://photos.prnewswire.com/prnh/20120726/CG47303-a) The new address is 5501 Wilshire Ave. NE, Suite D, Albuquerque, NM 87113. Phone and fax information remains the same; (505) 338 - 6100, fax (50...

Athleta Esprit de She Celebrates the Art of Fitness at Nationally Renowned Cherry Creek Arts Festival July 6

Life Time – The Healthy Way of Life Company (NYSE:LTM) announced today that its premiere athletic event series designed exclusively for women, Athleta Esprit de She – The Spirit of Her Race Series, will be featured as part of the world-class and award-winning Cherry Creek Arts Festival on July 6. The Athleta Esprit de She Run will featur...

Miltenyi Biotec Acquires Owl biomedical

Microchip cell sorting technology broadens cell isolation capabilities Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems ...

Communicating for America Members Overwhelmingly Support New Bipartisan Immigration Reform Legislation

FERGUS FALLS, Minn., April 30, 2013 (GLOBE NEWSWIRE) -- More than 92 percent of Communicating for America (CA) members working in agriculture support the recently released bipartisan comprehensive immigration bill, according to a recent survey. Additionally, more than 97% agreed that the current H-2A regulations are overly cumbersome, and put those farmers who play by the rules at a competitive d...

Iluvien regulatory update

Search BioPortfolio:
Loading
Advertisement
Advertisement